Development of evidence-based nursing recommendations for hand-foot syndrome in breast cancer chemotherapy patients
- 1Liuzhou Hospital of Guangzhou Women and Children’s Medical Center
Abstract
Objective: To develop evidence-based nursing recommendations for managing hand-foot syndrome (HFS) in breast cancer patients undergoing chemotherapy.
Methods: Based on the JBI evidence-based healthcare model, relevant literature was systematically reviewed. Following group analysis and discussion, preliminary nursing recommendations were drafted. Subsequently, two rounds of Delphi expert consultation were conducted two weeks apart with twenty experts from breast surgery, dermatology, and pharmacy departments across ten tertiary Grade A hospitals located in Beijing, Shanghai, Guangzhou, Henan, Qinghai, and other regions. Expert feedback was used to revise and refine the recommendations, resulting in a final version.
Results: The response rate for both rounds of expert consultation was 100%. The expert authority coefficients were 0.854 and 0.862, respectively, indicating strong expertise and reliable judgments. The coefficients of variation for expert ratings across the indicators ranged from 0.00 to 0.41 in the first round and from 0.00 to 0.13 in the second round. Kendall’s coefficients of concordance among experts across all indicators were 0.214 and 0.312, respectively (P<0.001), indicating a satisfactory level of expert consensus. The finalized nursing recommendations comprise 6 first-level domains (Assessment, Basic Prevention, Care During Treatment, Health Education, Psychosocial Support, and Follow-up) and 29 second-level items.
Conclusion: The evidence-based nursing recommendations developed in this study demonstrate strong scientific rigor and practical applicability. It can serve as a reference for managing HFS in breast cancer patients undergoing chemotherapy and have potential for clinical implementation and broader dissemination.
Related
- Focused Update to International Consensus Recommendations for the Use of Prolonged‐Infusion Beta‐Lactam Antibiotics Among Severely Ill Adult Patients: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists
- First reported clinical implementation of pressurized intraperitoneal aerosol chemotherapy in Japan: Program development and 30-day outcomes in two patients
- Development and Validation of a Gene Expression‐Based Prognostic Model for Patients With Small Cell Lung Cancer Treated With Chemotherapy
- Development and validation of a nomogram predicting pathologic complete response to neoadjuvant chemotherapy in luminal type breast cancer patients using MammaPrint® and clinicopathological factor
- Development and validation of a risk prediction model for demoralization syndrome in patients with chronic heart failure
BibTeX
@article{huang2026development,
title = {{Development of evidence-based nursing recommendations for hand-foot syndrome in breast cancer chemotherapy patients}},
author = {Liuqin Huang and Haixia Lu and Ying Zhou and Jiaqi Yuan and Dongmei Lan and Yan Xu},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1961472},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1961472/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Development of evidence-based nursing recommendations for hand-foot syndrome in breast cancer chemotherapy patients
AU - Liuqin Huang
AU - Haixia Lu
AU - Ying Zhou
AU - Jiaqi Yuan
AU - Dongmei Lan
AU - Yan Xu
PY - 2026
DA - 2026/10/29
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1961472
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1961472/full
AB - Objective: To develop evidence-based nursing recommendations for managing hand-foot syndrome (HFS) in breast cancer patients undergoing chemotherapy. Methods: Based on the JBI evidence-based healthcare model, relevant literature was systematically reviewed. Following group analysis and discussion, preliminary nursing recommendations were drafted. Subsequently, two rounds of Delphi expert consultation were conducted two weeks apart with twenty experts from breast surgery, dermatology, and pharmacy departments across ten tertiary Grade A hospitals located in Beijing, Shanghai, Guangzhou, Henan, Qinghai, and other regions. Expert feedback was used to revise and refine the recommendations, resulting in a final version. Results: The response rate for both rounds of expert consultation was 100%. The expert authority coefficients were 0.854 and 0.862, respectively, indicating strong expertise and reliable judgments. The coefficients of variation for expert ratings across the indicators ranged from 0.00 to 0.41 in the first round and from 0.00 to 0.13 in the second round. Kendall’s coefficients of concordance among experts across all indicators were 0.214 and 0.312, respectively (P<0.001), indicating a satisfactory level of expert consensus. The finalized nursing recommendations comprise 6 first-level domains (Assessment, Basic Prevention, Care During Treatment, Health Education, Psychosocial Support, and Follow-up) and 29 second-level items. Conclusion: The evidence-based nursing recommendations developed in this study demonstrate strong scientific rigor and practical applicability. It can serve as a reference for managing HFS in breast cancer patients undergoing chemotherapy and have potential for clinical implementation and broader dissemination.
SN - 2234-943X
ER -